Alzamend Neuro (ALZN) Receivables - Other (2020 - 2022)

Alzamend Neuro has disclosed Receivables - Other across 3 years of filings, most recently posting $9413.0 for Q3 2022.

• In Q3 2022, Receivables - Other fell 41.93% year-over-year to $9413.0; the TTM figure through Jul 2022 stood at $9413.0 (down 41.93% YoY), while the FY2021 annual figure was $16210.0, down 83.94% from the prior year.
• Receivables - Other came in at $9413.0 for Q3 2022 at Alzamend Neuro, down from $16210.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $100915.0 in Q2 2020 to a low of $9413.0 in Q3 2022.
• Average Receivables - Other over 3 years is $31791.6, with a median of $16210.0 recorded in 2021.
• Year-over-year, Receivables - Other plunged 83.94% in 2021 and slumped 41.93% in 2022.
• Over 3 years, Receivables - Other stood at $100915.0 in 2020, then sank by 83.94% to $16210.0 in 2021, then plunged by 41.93% to $9413.0 in 2022.
• Per Business Quant data, the three most recent Receivables - Other figures were $9413.0 in Q3 2022, $16210.0 in Q4 2021, and $16210.0 in Q3 2021.